Restart Life Sciences (NMLSD)
OTHER OTC:NMLSD
Holding NMLSD?
Track your performance easily

Restart Life Sciences (NMLSD) Financial Statements

20 Followers

Restart Life Sciences Financial Overview

Restart Life Sciences's market cap is currently ―. The company's EPS TTM is $-0.015; its P/E ratio is -0.64; Restart Life Sciences is scheduled to report earnings on November 26, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue--C$ -28.35KC$ 28.35K-
Gross Profit--C$ -28.35KC$ 28.35K-
EBITC$ -90.58KC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79K
EBITDAC$ -90.00KC$ -143.80KC$ -210.29KC$ -181.86KC$ -302.06K
Net Income Common StockholdersC$ -90.58KC$ -144.38KC$ -209.56KC$ -184.06KC$ -302.79K
Balance Sheet-
Cash Cash Equivalents And Short Term InvestmentsC$ 12.06KC$ 21.82KC$ 8.09KC$ 24.44KC$ 17.44K
Total AssetsC$ 26.35KC$ 40.10KC$ 31.06KC$ 53.89KC$ 61.48K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -12.06KC$ -21.82KC$ -8.09KC$ -24.44KC$ -17.44K
Total LiabilitiesC$ 1.07MC$ 995.08KC$ 841.66KC$ 654.93KC$ 478.46K
Stockholders EquityC$ -1.05MC$ -954.98KC$ -810.60KC$ -601.04KC$ -416.98K
Cash Flow-
Free Cash FlowC$ -9.76KC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50K
Operating Cash FlowC$ -9.76KC$ -46.27KC$ 251.82KC$ -261.18KC$ -96.50K
Investing Cash Flow-----
Financing Cash Flow-C$ 60.00KC$ -19.10KC$ 19.10K-
Currency in CAD

Restart Life Sciences Earnings and Revenue History

Restart Life Sciences Debt to Assets

Restart Life Sciences Cash Flow

Restart Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis